highflow
nasal
cannula
hfnc
wide
use
ventilatori
support
children
bronchiol
intens
care
set
data
avail
hfnc
use
gener
pediatr
ward
aim
studi
evalu
feasibl
hfnc
oxygen
therapi
infant
hospit
pediatr
ward
moderatesever
bronchiol
assess
chang
ventilatori
paramet
start
hfnc
support
prospect
observ
pilot
studi
carri
bronchiol
season
pediatr
tertiari
care
academ
center
itali
interrupt
hfnc
therapi
possibl
side
effect
escal
form
respiratori
support
record
oxygen
satur
spo
endtid
carbon
dioxid
etco
respiratori
rate
rr
measur
baselin
period
h
specif
time
interv
h
start
hfnc
record
twentyseven
infant
includ
median
age
month
absolut
rang
advers
event
prematur
hfnc
therapi
termin
escal
form
respiratori
support
record
median
spo
significantli
increas
point
chang
standard
oxygen
hfnc
p
median
etco
rr
rapidli
decreas
mmhg
breath
per
minut
respect
first
h
hfnc
therapi
p
remain
steadi
thereaft
conclus
use
hfnc
oxygen
administr
feasibl
infant
moderatesever
bronchiol
gener
pediatr
ward
children
hfnc
therapi
improv
oxygen
satur
level
seem
associ
decreas
etco
rr
bronchiol
common
lower
respiratori
tract
infect
first
year
life
lead
caus
hospit
infant
despit
grow
literatur
investig
treatment
option
recent
posit
data
use
nebul
hyperton
salin
epinephrin
oxygen
supplement
still
remain
mainstay
therapi
oxygen
therapi
administ
heat
humidifi
highflow
nasal
cannula
hfnc
shown
reduc
intub
rate
improv
respiratori
distress
children
hospit
intens
care
unit
bronchiol
hfnc
proven
well
toler
noninvas
respiratori
support
provid
humidifi
heat
airoxygen
blend
flow
lmin
hfnc
thought
improv
ventilatori
statu
prevent
mucou
dryness
improv
mucousciliari
clearanc
reduct
energi
expenditur
ga
warm
humidif
provis
continu
posit
airway
pressur
contribut
mainten
patent
alveoli
improv
ventilationperfus
mismatch
prevent
microatelectasi
advantag
hfnc
nasal
continu
posit
airway
pressur
ie
eas
use
improv
toler
minim
nasal
trauma
led
increas
util
also
outsid
intens
care
unit
howev
current
lack
data
feasibl
hfnc
infant
bronchiol
manag
pediatr
ward
effect
ventil
statu
thoroughli
investig
hfnc
oxygen
therapi
introduc
standard
care
institut
use
patient
bronchiol
admit
gener
pediatr
ward
sinc
septemb
decis
base
local
expert
consensu
aim
studi
evalu
feasibl
oxygen
therapi
administ
via
hfnc
infant
hospit
moderatesever
bronchiol
regular
pediatr
ward
assess
chang
ventilatori
paramet
start
hfnc
support
prospect
observ
pilot
studi
admit
infant
moderatesever
bronchiol
receiv
hfnc
oxygen
therapi
pediatr
ward
univers
padova
hospit
itali
novemb
april
pediatr
depart
provid
pediatr
intens
care
unit
picu
rapid
admiss
process
deterior
inpati
educ
hfnc
use
provid
medic
nurs
staff
work
gener
pediatr
ward
mean
dedic
halfday
cours
includ
lectur
practic
ie
handson
session
assembl
hfnc
devic
dispos
materi
provid
good
equip
mainten
monitor
good
function
cours
dedic
procedur
hfnc
use
also
avail
qualiti
system
hospit
intranet
train
member
respiratori
team
readili
avail
case
problem
relat
hfnc
use
bronchiol
defin
first
viral
episod
respiratori
distress
accompani
coryza
cough
crepit
andor
wheez
day
diseas
count
date
onset
respiratori
symptom
rhinorrhea
cough
respiratori
distress
report
parent
neonat
infant
age
day
month
hospit
first
episod
moderatesever
bronchiol
requir
oxygen
therapi
enrol
studi
exclus
criteria
includ
recurr
wheez
underli
hemodynam
signific
heart
diseas
chronic
lung
diseas
neuromuscular
diseas
oxygen
therapi
home
tracheostomi
bronchiol
sever
assess
accord
emerg
depart
bronchiol
protocol
use
score
adapt
wang
et
al
see
appendix
moder
bronchiol
defin
score
sever
score
accord
protocol
children
moder
sever
bronchiol
receiv
oxygen
therapi
nebul
hyperton
salin
present
oxygen
satur
ie
point
item
oxygen
satur
sever
score
see
appendix
children
moderatesever
bronchiol
need
oxygen
supplement
accord
emerg
depart
protocol
includ
studi
hyperton
salin
introduc
standard
care
emerg
depart
sinc
patient
moderatesever
bronchiol
need
oxygen
supplement
base
local
expert
consensu
avail
evid
trial
nebul
salbutamol
given
audibl
wheez
present
children
sever
bronchiol
receiv
oxygen
therapi
nebul
epinephrin
mgkg
hyperton
salin
emerg
depart
standard
oxygen
therapi
lmin
regular
nasal
cannula
administ
hfnc
oxygen
therapi
start
infant
admit
ward
unanticip
interrupt
hfnc
oxygen
therapi
due
difficulti
manag
devic
patient
intoler
nasal
cannula
report
either
nurs
medic
staff
record
side
effect
hfnc
use
nasal
mucosa
trauma
andor
bleed
vomit
possibl
result
gastric
distens
pneumothorax
well
need
escal
form
respiratori
support
monitor
record
data
collect
dedic
checklist
form
review
daili
ward
round
enter
electron
databas
along
patient
data
collect
clinic
report
form
oxygen
satur
respiratori
rate
rr
heart
rate
hr
bodi
temperatur
endtid
carbon
dioxid
etco
record
patient
baselin
period
h
hfnc
posit
oxygen
satur
baselin
record
standard
oxygen
room
air
paramet
record
h
h
h
h
h
h
h
start
hfnc
nasopharyng
aspir
viral
detect
real
time
pcr
perform
infant
addit
test
undertaken
accord
treat
physician
vital
sign
monitor
spo
hr
record
use
monitor
agil
rr
manual
measur
count
breath
per
minut
endtid
co
monitor
use
nasal
cannula
philip
capnolin
h
infantneonat
specif
infant
less
kg
connect
monitor
agil
nasal
cannula
oxygen
administr
remov
time
requir
etco
measur
capnographi
monitor
min
time
valu
record
everi
final
etco
valu
use
data
analysi
mean
six
record
everi
minut
fisher
paykel
healthcar
heat
humidifi
hfnc
system
humidif
system
kit
optiflow
oxygen
cannula
fisher
paykel
healthcar
auckland
new
zealand
use
patient
lowresist
nasal
cannula
fisher
paykel
healthcar
includ
intermedi
cannula
bc
base
diamet
mm
tip
diamet
mm
maximum
flow
rate
lmin
pediatr
cannula
bc
base
diamet
mm
tip
diamet
mm
maximum
flow
rate
lmin
size
cannula
fit
child
nare
without
occlus
flow
rate
determin
use
deriv
formula
flow
rate
liter
per
minut
weight
kilogram
maximum
flow
rate
lmin
constant
flow
temperatur
choic
made
order
deliv
flow
greater
patient
minut
ventil
effect
fraction
inspir
oxygen
fio
equal
nasal
cannula
oxygen
concentr
prevent
mix
room
air
minim
possibl
advers
event
relat
deliveri
inadvert
high
posit
end
expiratori
pressur
patient
system
integr
pressur
relief
valv
manifold
input
port
limit
maximum
system
pressur
valv
set
h
inspir
oxygen
concentr
adjust
achiev
spo
flow
rate
wean
lmin
everi
h
adequ
oxygen
satur
maintain
fio
hfnc
stop
switch
standard
oxygen
therapi
necessari
patient
remain
stabl
flow
lmin
continu
variabl
express
median
absolut
rang
overal
comparison
repeat
measur
time
carri
mean
friedman
test
twoway
analysi
varianc
rank
comparison
measur
baselin
time
point
initi
hfnc
carri
mean
wilcoxon
test
pair
sampl
categor
variabl
express
number
percentag
paramet
display
p
consid
statist
signific
statist
analys
conduct
use
statist
program
medcalc
studi
review
approv
hospit
ethic
committe
approv
number
inform
consent
obtain
parent
legal
guardian
infant
less
year
age
hospit
bronchiol
studi
period
elig
mild
bronchiol
clinic
score
thirtyeight
patient
present
moderatesever
bronchiol
final
enrol
fig
demograph
clinic
characterist
studi
patient
report
tabl
twentytwo
patient
month
age
nineteen
patient
hospit
decemb
januari
case
unanticip
interrupt
hfnc
oxygen
administr
therapi
well
toler
studi
patient
need
sedat
case
pneumothorax
report
advers
event
none
studi
patient
admit
intens
care
unit
need
escal
form
respiratori
support
chang
standard
oxygen
hfnc
show
statist
signific
increas
tabl
median
fio
administ
achiev
target
satur
set
devic
first
h
slightli
reduc
thereaft
pilot
studi
describ
use
oxygen
therapi
deliv
via
hfnc
infant
hospit
moderatesever
bronchiol
pediatr
ward
effect
ventilatori
paramet
result
show
hfnc
oxygen
therapi
feasibl
deliveri
system
oxygen
administr
pediatr
ward
provid
optim
oxygen
satur
level
associ
decreas
etco
rr
effect
noninvas
respiratori
support
children
moderatesever
bronchiol
import
order
improv
comfort
reduc
work
breath
prevent
complic
atelectasi
well
progress
respiratori
exhaust
may
lead
respiratori
failur
hfnc
respiratori
support
welltoler
advers
effect
children
preterm
neonat
pediatr
neonat
intens
care
unit
preterm
infant
hfnc
mainli
evalu
treatment
apnea
prematur
respiratori
distress
syndrom
prevent
extub
failur
howev
effect
compar
tradit
nasalcpap
rigor
studi
increas
avail
hfnc
devic
intens
care
set
past
year
well
toler
eas
use
prompt
use
respiratori
diseas
bronchiol
first
studi
assess
use
hfnc
children
bronchiol
carri
picu
unit
state
australia
mckiernan
et
al
retrospect
studi
children
introduct
hfnc
season
introduct
hfnc
show
decreas
intub
decreas
median
picu
length
stay
day
introduct
hfnc
australian
investig
note
declin
intub
rate
advers
event
retrospect
chart
review
period
children
bronchiol
treat
hfnc
picu
similar
result
studi
found
reduct
respiratori
rate
min
initi
hfnc
therapi
random
control
trial
infant
bronchiol
show
higher
median
spo
patient
acknowledg
author
studi
limit
small
sampl
size
nonblind
intervent
lack
formal
measur
pulmonari
mechan
ga
exchang
author
express
concern
possibl
hfnc
therapi
high
concentr
oxygen
may
provid
fals
reassur
oxygen
sick
infant
fact
tire
studi
show
hfnc
offer
ventilatori
support
well
reflect
steadi
decreas
etco
rr
pair
comparison
perform
valu
valu
time
point
start
hnfc
data
report
median
absolut
rang
etco
p
comparison
rr
p
comparison
hr
p
ns
comparison
spo
p
comparison
valu
record
room
air
baselin
hfnc
p
comparison
valu
record
regular
nasal
cannula
deliv
oxygen
baselin
hfnc
rr
respiratori
rate
hr
heart
rate
spo
oxygen
satur
fio
fraction
inspir
oxygen
hfnc
highflow
nasal
cannula
ns
signific
nc
regular
nasal
cannula
deliv
oxygen
initi
hfnc
oxygen
deliveri
none
children
need
escal
form
respiratori
support
suggest
decreas
etco
rr
may
identifi
respond
therapi
studi
shibler
et
al
respond
hfnc
show
decreas
rr
within
min
start
hfnc
therapi
wherea
nonrespond
show
littl
chang
rr
etco
howev
measur
recent
studi
carri
picu
shown
decreas
rr
infant
bronchiol
respond
hfnc
therapi
compar
nonrespond
group
author
report
decreas
pco
blood
ga
analysi
significantli
higher
initi
pco
valu
nonrespond
patient
measur
etco
capnographi
noninvas
indirect
measur
blood
co
tension
fast
respons
time
chang
blood
level
allow
visual
inspect
chang
co
concentr
mean
waveform
display
princip
determin
etco
alveolar
ventil
pulmonari
perfus
cardiac
output
metabol
statu
present
studi
first
evalu
effect
hfnc
therapi
ga
exchang
mean
etco
measur
patient
bronchiol
despit
arteri
blood
ga
analysi
gold
standard
monitor
partial
pressur
arteri
carbon
dioxid
invas
procedur
rare
use
admiss
later
clinic
improv
patient
bronchiol
increas
stress
work
breath
acut
ill
infant
may
turn
worsen
respiratori
statu
etco
shown
good
correl
capillari
arteri
co
adult
children
especi
use
detect
trend
ventilatori
statu
studi
sever
limit
first
random
control
trial
differ
standard
oxygen
therapi
evalu
compar
term
effect
ventil
statu
length
stay
effect
prevent
need
ventilatori
support
lack
comparison
group
allow
control
confound
factor
may
argu
intervent
nasal
suction
use
hyperton
salin
salbutamoladrenalin
ed
stay
might
influenc
find
howev
case
improv
etco
rr
would
expect
children
receiv
mention
intervent
oppos
steadi
etco
rr
valu
found
time
studi
nevertheless
even
signific
decreas
paramet
record
hfnc
start
delay
contribut
intervent
complet
exclud
compar
studi
cohort
sampl
size
mainli
includ
young
infant
month
age
commonli
higher
risk
moderatesever
diseas
narrow
respiratori
airway
reduc
respiratori
reserv
higher
metabol
demand
peculiar
featur
may
explain
longer
length
stay
studi
data
hfnc
influenc
length
stay
drawn
studi
design
recent
spanish
studi
assess
effect
hfnc
similar
cohort
young
patient
ward
report
similar
result
term
durat
oxygen
therapi
median
day
length
hospit
median
day
final
small
sampl
size
studi
note
howev
design
pilot
studi
result
may
provid
use
data
futur
welldesign
random
control
trial
possibl
manag
infant
bronchiol
outsid
picu
import
econom
implic
pediatr
critic
care
expens
sometim
difficult
access
contrast
nasalcpap
often
poorli
toler
impract
outsid
intens
care
set
hfnc
provid
welltoler
easi
use
safe
respiratori
support
consid
infant
moderatesever
bronchiol
need
oxygen
supplement
hospit
pediatr
ward
despit
fact
small
sampl
size
allow
properli
assess
safeti
intervent
ward
possibl
harm
relat
hfnc
rare
accord
publish
literatur
far
one
report
signific
pneumothorax
requir
intub
report
child
receiv
hfnc
flow
lmin
bronchiol
howev
result
support
hfnc
safe
introduc
wide
gener
pediatr
ward
even
center
provid
intens
care
unit
facil
set
care
medic
judgment
base
patient
clinic
statu
knowledg
system
network
pathway
deterior
patient
alway
drive
clinic
decis
make
first
place
random
control
studi
need
confirm
find
pilot
studi
assess
hfnc
effect
outcom
improv
enter
feed
reduct
transfer
intens
care
unit
intub
rate
length
hospit
well
longterm
benefit
econom
impact
healthcar
system
use
hfnc
oxygen
administr
feasibl
infant
moderatesever
bronchiol
hospit
ward
need
supplement
oxygen
hfnc
therapi
improv
oxygen
satur
level
seem
associ
decreas
etco
rr
laura
cesca
contribut
recruit
patient
data
collect
author
also
thank
head
nurs
ms
francesca
selmin
ms
mariella
rubin
nurs
preciou
support
research
project
medic
capnographi
compani
hold
three
patent
area
capnographi
author
conflict
interest
fund
disclos
author
receiv
financi
support
salari
person
benefit
fisher
paykel
healthcar
present
studi
hold
stock
compani
bronchiol
sever
score
modifi
wang
et
al
